Ethical Drug Development for Rare Childhood Diseases: When There Are Limited But Promising Data in Adults, How to Choose Between Safety or Efficacy Studies?
Liza-Marie Marie JohnsonDevan M DuenasBenjamin S WilfondPublished in: The American journal of bioethics : AJOB (2020)